AbCellera Biologics Inc.
Ticker: 1703057
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY2026 | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 4.05-51.3% | 8.32-7.1% | 8.96-47.5% | 17.08+302.8% | 4.24-34.9% | 6.51-11.1% | 7.32-26.4% | 9.95 |
| Total Income | 4.05-51.3% | 8.32-7.1% | 8.96-47.5% | 17.08+302.8% | 4.24-34.9% | 6.51-11.1% | 7.32-26.4% | 9.95 |
| EXPENSES | ||||||||
| Expenditure | 66.83+1.5% | 65.83-22.8% | 85.23+27.8% | 66.67-0.3% | 66.90-33.2% | 100.17-0.6% | 100.78+55.4% | 64.85 |
| Tax | -3.54+44.4% | -6.37+45.3% | -11.65-619.1% | -1.62+78.0% | -7.36+36.2% | -11.53-2.4% | -11.26-426.2% | -2.14 |
| PROFIT | ||||||||
| PBT | -58.97-19.0% | -49.54+28.0% | -68.77-89.2% | -36.34+31.4% | -52.98+15.4% | -62.63-30.0% | -48.19-12.7% | -42.75 |
| Net Profit | -55.43-28.4% | -43.17+24.4% | -57.12-64.5% | -34.73+23.9% | -45.62+10.7% | -51.11-38.4% | -36.93+9.1% | -40.61 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.18-28.6% | -0.14+26.3% | -0.19-58.3% | -0.12+20.0% | -0.15+11.8% | -0.17-30.8% | -0.13+7.1% | -0.14 |
Corporate Events
Board MeetingABCL
20265Aug
Board Meeting
Q2 2026 Earnings Conference Call — AbCellera Biologics Inc. …
SEC Filing ↗ Board MeetingABCL
202630Jun
Board Meeting
Appointment of Lynn Seely, M.D. as a new Class III independe…
SEC Filing ↗ Board MeetingABCL
202611Jun
Board Meeting
Annual Meeting of Shareholders to elect two Class III direct…
SEC Filing ↗ Board MeetingABCL
20261Jun
Board Meeting
Appointment of Victor Sandor as an independent director to t…
SEC Filing ↗ Board MeetingABCL
202611May
Board Meeting
AbCellera Biologics Inc. reported its Q1 2026 financial resu…
SEC Filing ↗